Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 426-437

  Cestari, Igor dos S ^a   Krarup, Anders ^b   Sim, Robert B ^b   Inal, Jameel M ^c   Ramirez, Marcel I ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Chagas disease; Complement system; CRIT; Lectin pathway; Trypanosoma cruzi

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT C2 RECEPTOR INHIBITOR TRISPANNING PROTEIN; COMPLEMENT COMPONENT C2; COMPLEMENT RECEPTOR; FICOLIN; LECTIN; MANNAN BINDING LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN FUNCTION; TRYPANOSOMA CRUZI;

ANIMALS; CELL DEATH; CELL MEMBRANE; COMPLEMENT C2; COMPLEMENT C4; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; GLYCOSYLATION; HUMANS; LECTINS; LIFE CYCLE STAGES; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SERUM; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 70450223706     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.08.030     Document Type: Article

References (42)

1. Almeida I.C., Ferguson M.A., Schenkman S., and Travassos L.R. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease. Braz. J. Med. Biol. Res. 27 (1994) 443-447
2. Almeida I.C., Milani S.R., Gorin P.A., and Travassos L.R. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies. J. Immunol. 146 (1991) 2394-2400
3. Ambrosio A.R., and De Messias-Reason I.J. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism. Parasite Immunol. 27 (2005) 333-340
4. Buscaglia C.A., Campo V.A., Frasch A.C., and Di Noia J.M. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat. Rev. Microbiol. 4 (2006) 229-236
5. Cestari I.d.S., Evans-Osses I., Freitas J.C., Inal J.M., and Ramirez M.I. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi. J. Infect. Dis. 198 (2008) 1276-1283
6. Contreras V.T., Salles J.M., Thomas N., Morel C.M., and Goldenberg S. In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol. Biochem. Parasitol. 16 (1985) 315-327
7. Devyatyarova-Johnson M., Rees I.H., Robertson B.D., Turner M.W., Klein N.J., and Jack D.L. The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms. Infect. Immun. 68 (2000) 3894-3899
8. Di Noia J.M., Buscaglia C.A., De Marchi C.R., Almeida I.C., and Frasch A.C. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. J. Exp. Med. 195 (2002) 401-413
9. Dominguez M., Moreno I., Lopez-Trascasa M., and Torano A. Complement interaction with trypanosomatid promastigotes in normal human serum. J. Exp. Med. 195 (2002) 451-459
10. Eisen D.P., Dean M.M., Boermeester M.A., Fidler K.J., Gordon A.C., Kronborg G., Kun J.F., Lau Y.L., Payeras A., Valdimarsson H., Brett S.J., Ip W.K., Mila J., Peters M.J., Saevarsdottir S., van Till J.W., Hinds C.J., and McBryde E.S. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin. Infect. Dis. 47 (2008) 510-516
11. Ferreira V., Valck C., Sanchez G., Gingras A., Tzima S., Molina M.C., Sim R., Schwaeble W., and Ferreira A. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J. Immunol. 172 (2004) 3042-3050
12. Garlatti V., Belloy N., Martin L., Lacroix M., Matsushita M., Endo Y., Fujita T., Fontecilla-Camps J.C., Arlaud G.J., Thielens N.M., and Gaboriaud C. Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J. 26 (2007) 623-633
13. Hummelshoj T., Munthe-Fog L., Madsen H.O., Fujita T., Matsushita M., and Garred P. Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum. Mol. Genet. 14 (2005) 1651-1658
14. Iida K., Whitlow M.B., and Nussenzweig V. Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components. J. Exp. Med. 169 (1989) 881-891
15. Inal J.M., Hui K.M., Miot S., Lange S., Ramirez M.I., Schneider B., Krueger G., and Schifferli J.A. Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor. J. Immunol. 174 (2005) 356-366
16. Inal J.M., and Schifferli J.A. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2. J. Immunol. 168 (2002) 5213-5221
17. Inal J.M., and Sim R.B. A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2. FEBS Lett. 470 (2000) 131-134
18. Kahn S., Wleklinski M., Aruffo A., Farr A., Coder D., and Kahn M. Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor. J. Exp. Med. 182 (1995) 1243-1258
19. Kipnis T.L., Krettli A.U., and Dias da Silva W. Transformation of trypomastigote forms of Trypanosoma cruzi into activators of alternative complement pathway by immune IgG fragments. Scand. J. Immunol. 22 (1985) 217-226
20. Krarup A., Mitchell D.A., and Sim R.B. Recognition of acetylated oligosaccharides by human L-ficolin. Immunol. Lett. 118 (2008) 152-156
21. Krarup A., Thiel S., Hansen A., Fujita T., and Jensenius J.C. L-ficolin is a pattern recognition molecule specific for acetyl groups. J. Biol. Chem. 279 (2004) 47513-47519
22. Krautz G.M., Kissinger J.C., and Krettli A.U. The targets of the lytic antibody response against Trypanosoma cruzi. Parasitol. Today 16 (2000) 31-34
23. Krettli A.U., and Pontes de Carvalho L.C. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade. Clin. Exp. Immunol. 62 (1985) 270-277
24. Lambris J.D., Ricklin D., and Geisbrecht B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6 (2008) 132-142
25. Lederkremer R.M., and Bertello L.E. Glycoinositolphospholipids, free and as anchors of proteins, in Trypanosoma cruzi. Curr. Pharm. Des. 7 (2001) 1165-1179
26. Macrae J.I., Acosta-Serrano A., Morrice N.A., Mehlert A., and Ferguson M.A. Structural characterization of NETNES, a novel glycoconjugate in Trypanosoma cruzi epimastigotes. J. Biol. Chem. 280 (2005) 12201-12211
27. Malhotra R., Wormald M.R., Rudd P.M., Fischer P.B., Dwek R.A., and Sim R.B. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1 (1995) 237-243
28. Matsushita M., Kuraya M., Hamasaki N., Tsujimura M., Shiraki H., and Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J. Immunol. 168 (2002) 3502-3506
29. Mota I., and Umekita L.F. The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies. Immunol. Lett. 21 (1989) 223-225
30. Nogueira N., Bianco C., and Cohn Z. Studies on the selective lysis and purification of Trypanosoma cruzi. J. Exp. Med. 142 (1975) 224-229
31. Norris K.A. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Infect. Immun. 66 (1998) 2460-2465
32. Pangburn M.K. Activation of complement via the alternative pathway. Fed. Proc. 42 (1983) 139-143
33. Ratier L., Urrutia M., Paris G., Zarebski L., Frasch A.C., and Goldbaum F.A. Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies. PLoS ONE 3 (2008) e3524
34. Roos A., Bouwman L.H., Munoz J., Zuiverloon T., Faber-Krol M.C., Fallaux-van den Houten F.C., Klar-Mohamad N., Hack C.E., Tilanus M.G., and Daha M.R. Functional characterization of the lectin pathway of complement in human serum. Mol. Immunol. 39 (2003) 655-668
35. Sim R.B., and Laich A. Serine proteases of the complement system. Biochem. Soc. Trans. 28 (2000) 545-550
36. Suankratay C., Zhang Y., Jones D., Lint T.F., and Gewurz H. Enhancement of lectin pathway haemolysis by immunoglobulins. Clin. Exp. Immunol. 117 (1999) 435-441
37. Tambourgi D.V., Kipnis T.L., da Silva W.D., Joiner K.A., Sher A., Heath S., Hall B.F., and Ogden G.B. A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF. Infect. Immun. 61 (1993) 3656-3663
38. Tan S.M., Chung M.C., Kon O.L., Thiel S., Lee S.H., and Lu J. Improvements on the purification of mannan-binding lectin and demonstration of its Ca(2+)-independent association with a C1s-like serine protease. Biochem. J. 319 Pt 2 (1996) 329-332
39. Teixeira A.R., Nitz N., Guimaro M.C., Gomes C., and Santos-Buch C.A. Chagas disease. Postgrad. Med. J. 82 (2006) 788-798
40. Thiel S., Frederiksen P.D., and Jensenius J.C. Clinical manifestations of mannan-binding lectin deficiency. Mol. Immunol. 43 (2006) 86-96
41. Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W., Laursen S.B., Poulsen K., Willis A.C., Eggleton P., Hansen S., Holmskov U., Reid K.B., and Jensenius J.C. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386 (1997) 506-510
42. Weis W.I., Drickamer K., and Hendrickson W.A. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 360 (1992) 127-134